HLIT250516P17500
- 0.00
- 0.000.00%
Harmonic Newsroom
Needham Maintains Harmonic(HLIT.US) With Buy Rating, Maintains Target Price $14
Northland Securities Maintains Harmonic(HLIT.US) With Buy Rating, Cuts Target Price to $12.5
Harmonic Is Maintained at Buy by Rosenblatt
Harmonic Analyst Ratings
Barclays Maintains Harmonic(HLIT.US) With Hold Rating, Cuts Target Price to $10
Rosenblatt Securities Maintains Harmonic(HLIT.US) With Buy Rating, Cuts Target Price to $11
Analysts' Opinions Are Mixed on These Technology Stocks: Roper Technologies (ROP), Harmonic (HLIT) and Qualys (QLYS)
Analysts Offer Insights on Technology Companies: Intuit (INTU), Varonis Systems (VRNS) and Harmonic (HLIT)
Analysts Are Bullish on Top Technology Stocks: Advanced Micro Devices (AMD), Harmonic (HLIT)
Raymond James Downgrades Harmonic(HLIT.US) to Hold Rating
Analysts Offer Insights on Industrial Goods Companies: Harmonic Drive Systems (OtherHSYDF) and Chart Industries (GTLS)
Third Harmonic Bio Cut to Hold From Buy by Stifel
Third Harmonic Bio Analyst Ratings
Stifel Nicolaus Downgrades Third Harmonic Bio to Neutral From Buy, Adjusts Price Target to $5 From $23
Bernstein Sticks to Their Buy Rating for Harmonic Drive Systems (HSYDF)
Bernstein Reaffirms Their Buy Rating on Harmonic Drive Systems (HSYDF)
Third Harmonic Bio Cut to Equal-Weight From Overweight by Morgan Stanley
Morgan Stanley Downgrades Third Harmonic Bio to Equal-Weight, Lowers Price Target to $5
Third Harmonic Bio, Inc.: Hold Rating Amid Strategic Uncertainty and Safety Concerns
Optimistic Buy Rating for Third Harmonic Bio Amid Promising Trial Results and Safety Concerns